잠시만 기다려 주세요. 로딩중입니다.

Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study

Obstetrics & Gynecology Science 2020년 63권 2호 p.150 ~ 157
 ( Carbajal-Mamani Semiramis L. ) - University of Florida College of Medicine Department of Medicine

 ( Schweer David ) - University of Florida College of Medicine Department of Obstetrics and Gynecology
 ( Markham Merry J. ) - University of Florida College of Medicine Department of Medicine
 ( Esnakula Ashwini K. ) - University of Florida College of Medicine Department of Pathology, Immunology, and Laboratory Medicine
 ( Grajo Joseph R. ) - University of Florida College of Medicine Department of Radiology
 ( Castagno Jacqueline C. ) - University of Florida College of Medicine Department of Obstetrics and Gynecology
 ( Cardenas-Goicoechea Joel ) - University of Florida College of Medicine Department of Obstetrics and Gynecology

Abstract


Objective: The primary objective was to assess the feasibility of robotic-assisted interval cytoreductive surgery for achieving complete cytoreduction for patients with advanced-stage ovarian cancer. The secondary objective was to examine the perioperative outcomes.

Methods: A retrospective study of 12 patients with stage IIIC or IV ovarian, fallopian tube, and primary peritoneal carcinoma who underwent interval cytoreductive surgery after neo-adjuvant chemotherapy.

Results: Optimal cytoreduction was achieved in 100% of selected patients. Complete cytoreductive surgery was achieved in 75% of patients. The estimated mean blood loss was 100 mL. The median length of hospital stay was 2 days. Perioperative complication and 30-day readmission rates were 8.3% (1 patient). The median follow-up time was 9.5 months.

Conclusion: Robotic-assisted interval cytoreductive surgery in ovarian cancer is safe and feasible and may be an alternative to standard laparotomy in selected patients.

키워드

Robotic surgical procedure; Ovarian cancer; Cytoreductive surgical procedure
원문 및 링크아웃 정보
 
등재저널 정보